隔膜起搏治疗系统市场：依产品、应用分类 - 2025-2030 年全球预测

隔膜起搏治疗系统市场2023年估值为50.3亿美元，预计到2024年将达到54亿美元，复合年增长率为7.39%，预计到2030年将达到82.9亿美元。

隔膜起搏治疗系统 (DPTS) 是一项医疗创新，旨在帮助患有脊髓损伤和自主呼吸困难的 ALS 患者。这项技术涉及透过手术植入刺激隔膜的电极，使患者能够更有效地呼吸。对 DPTS 的需求源于对机械人工呼吸器，机械呼吸器有感染疾病和生活品质下降等风险。 DPTS 可以增加患者的活动能力并提高生活质量，因此其应用在医院和家庭护理环境中非常重要。最终用途范围包括医疗保健设施和居家医疗服务，主要针对患有慢性呼吸道疾病的患者。 DPTS 市场的主要驱动力是医疗技术的进步、呼吸系统疾病病例的增加以及对以患者为中心的护理的日益支持。重要的成长机会在于透过政府医疗保健计划和与保险公司合作扩大地理可近性和负担能力。然而，高昂的成本、有限的患者和医疗保健专业人士意识以及严格的监管要求是显着的挑战。创新可以集中在非侵入性起搏技术、提高电池寿命、开发更紧凑的系统等，并旨在提高采用率并进一步纳入现有的医疗通讯协定。它还可以研究个人化治疗计划和自适应起搏系统。儘管这个市场是一个以技术快速进步为特征的动态市场，但仍需要在意识和培训方面进行投资，以克服教育障碍并优化 DPTS 在传统医疗环境中的使用。公司应制定策略，透过增加新兴国家的研发力度并利用远端医疗，确保创新满足不断变化的临床需求。总体而言，透过与政府和非营利组织合作来降低成本和提高可及性，可以有效确保市场成长，并为依赖机械支援系统的患者带来显着利益。

市场动态：快速发展的隔膜起搏治疗系统市场的关键市场洞察

隔膜起搏治疗系统市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

• 市场驱动因素
  • 脊髓损伤和肌萎缩侧索硬化症 (ALS) 的发生率增加
  • 由于 DPTS 的优势，采用率有所提高
  • 侵入性机械通气 (IMV)併发症导致需求激增
• 市场限制因素
  • 製造业价格上涨
• 市场机会
  • 投资于产品成本效益和先进性
  • 膈肌起搏治疗系统的研发活动增加
• 市场挑战
  • 核准週期较长

波特五力：驾驭隔膜起搏治疗系统市场的策略工具

波特的五力框架是了解隔膜起搏治疗系统市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解隔膜起搏治疗系统市场的外部影响

外部宏观环境因素在塑造隔膜起搏治疗系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解隔膜起搏治疗系统市场的竞争格局

对隔膜起搏治疗系统市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵隔膜起搏治疗系统市场供应商的绩效评估

FPNV 定位矩阵是评估隔膜起搏治疗系统市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了隔膜起搏治疗系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，隔膜起搏治疗系统市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 脊髓损伤和肌萎缩侧索硬化症 (ALS) 的发生率增加
    • 采用率的提高超过了 DPTS 的优势
    • 侵入性人工呼吸器(IMV)併发症导致需求激增
  • 抑制因素
    • 生产成本上升
  • 机会
    • 投资于产品成本效益和先进性
    • 膈肌起搏治疗系统的研发活动增加
  • 任务
    • 延长核准期限
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章隔膜起搏治疗系统市场：依产品

• 隔膜心律调节器
• 心律调节器

第七章隔膜起搏治疗系统市场：依应用分类

• 肌萎缩侧索硬化症
• 脊髓损伤

第八章北美和南美隔膜节律治疗系统市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太隔膜起搏治疗系统市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章欧洲、中东和非洲隔膜起搏治疗系统市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• Atrotech Oy
• Avery Biomedical Devices, Inc
• Koninklijke Philips NV
• Lungpacer Medical, Inc
• Synapse Biomedical Inc.

The Diaphragm Pacing Therapy System Market was valued at USD 5.03 billion in 2023, expected to reach USD 5.40 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 8.29 billion by 2030.

The Diaphragm Pacing Therapy System (DPTS) is a medical innovation designed to assist individuals with conditions like spinal cord injuries or ALS, which impair the ability to breathe independently. This technology involves surgically implanting electrodes that stimulate the diaphragm, allowing patients to breathe more effectively. The necessity of DPTS arises from the high demand for alternatives to mechanical ventilators, which carry risks such as infections and reduced quality of life. DPTS allows for greater patient mobility and improved life quality, making its application critical in hospitals and home care settings. End-use scope primarily involves healthcare facilities and home healthcare services catering to patients with chronic respiratory issues. The DPTS market is primarily driven by advancements in medical technology, increasing cases of respiratory disorders, and greater advocacy for patient-centric care. Significant growth opportunities lie in expanding geographic accessibility and enhancing affordability through governmental health initiatives and partnerships with insurance providers. However, high costs, limited awareness among patients and healthcare professionals, and stringent regulatory requirements are notable challenges. Innovations could focus on non-invasive pacing techniques, improving battery life, and creating more compact systems, aiming to increase adoption and further integrate into existing healthcare protocols. Research can also explore personalized therapy plans and adaptive pacing systems. The market is dynamic, characterized by rapid technological advancements, yet requires investment in awareness and training initiatives to overcome educational barriers and optimize the utilization of DPTS in more conventional medical contexts. Companies should strategize on enhancing their R&D efforts in emerging economies and leveraging telemedicine to expand their reach, ensuring that innovation aligns with evolving clinical needs. Overall, targeting cost reduction and improving accessibility through collaborations with governments and non-profits could effectively secure market growth and provide significant benefits to patients reliant on mechanical support systems.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diaphragm Pacing Therapy System Market

The Diaphragm Pacing Therapy System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of spinal cord injuries and amyotrophic lateral sclerosis (ALS)
  • Increasing adoption over advantages of DPTS
  • Demand upsurge due to invasive mechanical ventilation (IMV) complications
• Market Restraints
  • High prices for production
• Market Opportunities
  • Investment for the cost-effectiveness and advancement of product
  • Increase in R&D activities across Diaphragm Pacing Therapy System
• Market Challenges
  • Prolonged approval period

Porter's Five Forces: A Strategic Tool for Navigating the Diaphragm Pacing Therapy System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diaphragm Pacing Therapy System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diaphragm Pacing Therapy System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diaphragm Pacing Therapy System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diaphragm Pacing Therapy System Market

A detailed market share analysis in the Diaphragm Pacing Therapy System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diaphragm Pacing Therapy System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diaphragm Pacing Therapy System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diaphragm Pacing Therapy System Market

A strategic analysis of the Diaphragm Pacing Therapy System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diaphragm Pacing Therapy System Market, highlighting leading vendors and their innovative profiles. These include Atrotech Oy, Avery Biomedical Devices, Inc, Koninklijke Philips N.V., Lungpacer Medical, Inc, and Synapse Biomedical Inc..

Market Segmentation & Coverage

This research report categorizes the Diaphragm Pacing Therapy System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Diaphragm Pacemaker and External Diaphragm Pacemaker.
• Based on Application, market is studied across Amyotrophic Lateral Sclerosis and Spinal Cord Injury.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of spinal cord injuries and amyotrophic lateral sclerosis (ALS)
    • 5.1.1.2. Increasing adoption over advantages of DPTS
    • 5.1.1.3. Demand upsurge due to invasive mechanical ventilation (IMV) complications
  • 5.1.2. Restraints
    • 5.1.2.1. High prices for production
  • 5.1.3. Opportunities
    • 5.1.3.1. Investment for the cost-effectiveness and advancement of product
    • 5.1.3.2. Increase in R&D activities across Diaphragm Pacing Therapy System
  • 5.1.4. Challenges
    • 5.1.4.1. Prolonged approval period
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diaphragm Pacing Therapy System Market, by Product

• 6.1. Introduction
• 6.2. Diaphragm Pacemaker
• 6.3. External Diaphragm Pacemaker

7. Diaphragm Pacing Therapy System Market, by Application

• 7.1. Introduction
• 7.2. Amyotrophic Lateral Sclerosis
• 7.3. Spinal Cord Injury

8. Americas Diaphragm Pacing Therapy System Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Diaphragm Pacing Therapy System Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Diaphragm Pacing Therapy System Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Atrotech Oy
• 2. Avery Biomedical Devices, Inc
• 3. Koninklijke Philips N.V.
• 4. Lungpacer Medical, Inc
• 5. Synapse Biomedical Inc.

LIST OF FIGURES

• FIGURE 1. DIAPHRAGM PACING THERAPY SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DIAPHRAGM PACING THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DIAPHRAGM PACING THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIAPHRAGM PACING THERAPY SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIAPHRAGM PACING THERAPY SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY DIAPHRAGM PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY EXTERNAL DIAPHRAGM PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. CANADA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. CHINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. INDIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ITALY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. POLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. QATAR DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. DIAPHRAGM PACING THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. DIAPHRAGM PACING THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023